Optimal use of thienopyridines in non-ST-elevation acute coronary syndrome following CURRENT-OASIS 7

Circ Cardiovasc Interv. 2011 Feb 1;4(1):95-103. doi: 10.1161/CIRCINTERVENTIONS.109.910406.

Authors

Johanne Silvain¹, Anne Bellemain-Appaix, Olivier Barthélémy, Farzin Beygui, Jean-Philippe Collet, Gilles Montalescot

Affiliation

¹ Institut de Cardiologie, INSERM UMRS-937, Pitié-Salpêtrière Hospital, Université Paris 6, 47 blvd. de l’Hôpital, Paris, France.

PMID: 21325198
DOI: 10.1161/CIRCINTERVENTIONS.109.910406

No abstract available

MeSH terms

Acute Coronary Syndrome / drug therapy*
Drug Therapy, Combination
Electrocardiography
Humans
Platelet Aggregation Inhibitors / administration & dosage*
Randomized Controlled Trials as Topic
Thienopyridines / administration & dosage*
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Thienopyridines